1. Home
  2. VIVO vs MYO Comparison

VIVO vs MYO Comparison

Compare VIVO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoPower PLC Ordinary Shares

VIVO

VivoPower PLC Ordinary Shares

N/A

Current Price

$3.89

Market Cap

80.1M

Sector

Utilities

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.44

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIVO
MYO
Founded
2014
2004
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Power Generation
Industrial Specialties
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.1M
68.9M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
VIVO
MYO
Price
$3.89
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
388.2K
778.5K
Earning Date
05-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,000,000.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$13.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40814.79
52 Week Low
$1.97
$0.61
52 Week High
$6.86
$1.89

Technical Indicators

Market Signals
Indicator
VIVO
MYO
Relative Strength Index (RSI) 41.40 48.09
Support Level $3.54 $1.36
Resistance Level $4.32 $1.89
Average True Range (ATR) 0.27 0.18
MACD -0.05 -0.04
Stochastic Oscillator 4.93 7.48

Price Performance

Historical Comparison
VIVO
MYO

About VIVO VivoPower PLC Ordinary Shares

VivoPower PLC is engaged in building, owning, and leasing powered land and data center infrastructure for AI compute applications. The group delivers specialized infrastructure solutions across the AI Data Centers, Power-to-X, and Electric Mobility. It is develop and operated infrastructure that enables sovereign nations and institutional partners to secure control over power, data, and national intelligence, supporting AI, compute-intensive workloads, and energy transition use cases.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

Share on Social Networks: